GLYXTRIO
Live / Registered — Registered (as of 27 Sept 2022)
What this means for you
Registered since 27 Sept 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88036691
- Registration number
- 6854831
- Mark type
- Stylized text
- Filed
- 13 Jul 2018
- Published for opposition
- 12 Jul 2022
- Registered
- 27 Sept 2022
- Attorney of record
- Sean P. McMahon
Goods and services
- Class 005 — Pharmaceuticals: (Based on 44(d) Priority Application) Pharmaceutical preparations for the treatment of metabolic and cardiovascular diseases(Based on 44(e)) Pharmaceutical preparations for the treatment of metabolic and cardiovascular diseases
Owner
- Boehringer Ingelheim International GmbH, Ingelheim, DE
- Boehringer Ingelheim International GmbH, Ingelheim, DE
- Boehringer Ingelheim International GmbH, Ingelheim, DE
Prosecution history
- 27 Sept 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 27 Sept 2022 — REGISTERED-PRINCIPAL REGISTER
- 12 Jul 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Jul 2022 — PUBLISHED FOR OPPOSITION
- 22 Jun 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Jun 2022 — ELECTRONIC RECORD REVIEW COMPLETE
- 03 Jun 2022 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 01 Jun 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Jun 2022 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 27 Oct 2021 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 21 Apr 2021 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 20 Oct 2020 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 08 Apr 2020 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 22 Mar 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 22 Mar 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED